Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cranford, New Jersey
- Most recent report
- 8-K, filed Aug 21, 2026
- Incorporated
- Nevada
- Filings on record
- 636 filings
- On EDGAR
- CIK 1506251
- Fiscal year ends
- September
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 62
News 8 of 188
Prospectuses and Registrations 8 of 94
- S-3 Shelf registration statement May 22, 2026
- 424B5 Prospectus supplement for an offering Apr 24, 2026
- 424B5 Prospectus supplement for an offering Oct 21, 2025
- 424B5 Prospectus supplement for an offering Jun 11, 2025
- 424B5 Prospectus supplement for an offering Apr 2, 2025
- 424B5 Prospectus supplement for an offering Jan 8, 2025
- 424B5 Prospectus supplement for an offering Nov 18, 2024
- 424B5 Prospectus supplement for an offering Aug 12, 2024
Proxies 8 of 26
- DEFA14A Extra proxy material Feb 24, 2026
- DEF 14A Proxy statement for a shareholder vote Feb 24, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- PRE 14A Preliminary proxy statement Apr 18, 2025
- DEFA14A Extra proxy material Jan 27, 2025
- DEF 14A Proxy statement for a shareholder vote Jan 27, 2025
- PRE 14A Preliminary proxy statement Jan 16, 2025
Ownership 8 of 155
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jun 4, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 17, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Dec 17, 2025
- SCHEDULE 13G Large holder reported a passive stake Oct 27, 2025
- 4 Insider reported a trade Sep 23, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Sep 12, 2025
- 4 Insider reported a trade Aug 12, 2025
Other 8 of 111
- UPLOAD Comment letter from SEC staff Aug 10, 2026
- EFFECT Notice that a registration became effective Jun 2, 2026
- CORRESP Reply to SEC staff May 29, 2026
- ARS Annual report sent to shareholders Feb 24, 2026
- ARS Annual report sent to shareholders Jan 27, 2025
- EFFECT Notice that a registration became effective Mar 1, 2024
- CORRESP Reply to SEC staff Feb 29, 2024
- UPLOAD Comment letter from SEC staff Feb 29, 2024
Everything here comes from Citius Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.